Hera Biotech, a San Antonio-based startup developing a nonsurgical diagnostic test for endometriosis, won the Pitch Perfect contest at MedCity News’ INVEST Digital Health conference. The average diagnostic delay for the endometriosis is eight years, driven in large part by the fact that the only method currently used to diagnose the disease is a surgical procedure.
Femtech was the theme of the INVEST Digital Health Pitch Perfect contest in Dallas this week. Seven companies presented their approaches to addressing women's health.
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
Memorial Hermann Health System in Houston struck a new partnership with Midi Health, a virtual care clinic focused exclusively on women who are navigating menopause. The health system's two main goals for the partnership are to provide another point of access for its patients to manage their health at home and to gather data to inform decisions about which services it should offer to meet women’s healthcare needs.
Allara raised $10 million in a Series A funding round led by GV. The startup offers membership-based virtual services to treat women's chronic hormonal conditions, such as PCOS and endometriosis. CEO Rachel Blank — former executive at Ro and investor at General Catalyst — founded the company partly due to the difficulty she experienced arriving at her own PCOS diagnosis.
A new survey shows that women want more comprehensive medical support, solutions that treat their specific health concerns, access to a doctor who identifies the root cause of their symptoms and better care management services.
In a value-based partnership with ApolloMed, SCAN is launching a Provider Specific Plan called Compass. It is also announcing a Medicare Advantage plan designed for women called SCAN Inspired.
Evvy's $14 million funding round was led by Left Lane Capital and included participation from General Catalyst, LabCorp Venture Fund, RH Capital, Ingeborg Investments, G9 Ventures, Virtue and Amboy Street Ventures. In total, Evvy has raised $19 million.
MedCity News is launching a new podcast called MedCity FemFwd, which will discuss the breakthroughs and challenges in the women's health space. In the inaugural episode, Michelle Long of KFF examines whether Opill — the first daily oral contraceptive approved for nonprescription use in the U.S. — will be covered by insurance.
A webinar sponsored by AVIA Health and SeamlessMD will discuss the latest trends in remote monitoring and how to extend these benefits beyond chronic conditions all while using fewer staff resources.
Visana Health's seed funding was led by Flare Capital Partners and Frist Cressey Ventures and included participation from InHealth Ventures, Oxeon Partners, Pixel Perfect Ventures and Venture Investors. In total, the company has raised more than $13 million.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
FemTech is at the forefront of providing effective solutions to menstrual challenges, and the efforts to normalize and destigmatize menstruation are paving the way for the democratization of women’s healthcare.
Traditionally offering family building support, Progyny is expanding into the menopause space. Employees of its employer customers will receive a personalized care plan that includes support for nutrition, sleep, mental health and hormonal health — all factors that affect menopause.
We need to create a care model that doesn’t treat menopause as some separate gray area of women’s health where doctors are unequipped and patients are left to their own devices to figure it out.
HerMD recently raised $18 million in a Series A-1 funding round. The company offers in-person and virtual women's healthcare that focuses on menopause and sexual health. It is using its new capital to open more brick-and-mortar women's health centers across the country.
Digital health startup Dorsata filed a lawsuit against EHR provider athenahealth and women’s health company Unified Women's Healthcare. The startup alleged that athenahealth stole trade secrets, used deceptive business practices and breached its contract — and that Unified aided and abetted these purported practices.
